RMD
ResMed Inc.
NYSE · USHealthcareMedical - Instruments & Supplies
$198.61-0.19%
Price as of Jul 20, 2026
RMD profitability
ResMed Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 61.7%
- EBITDA margin
- 39.5%
- EBIT margin
- 34.3%
- Net margin
- 27.4%
- Free cash flow margin
- 31.6%
Returns
- Return on equity
- 23.4%
- Return on assets
- 17.3%
- Return on invested capital
- 25.9%
- Asset turnover
- 0.64x
Cash efficiency
- Cash from operations
- $1.9B
- Cash per share
- $11
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.